Finding the Nominator: Singapore’s Register of Nominee Directors and the Convergence of Beneficial Ownership Transparency

A Singapore law perspective for international practitioners, ahead of the EU nominee disclosure obligations that apply from 10 July 2027.

1. Why this matters outside Singapore

For European and international counsel, the Singapore nominee director is not an exotic topic. It appears in almost every inbound structure. Section 145(1) of the Companies Act 1967 requires every Singapore-incorporated company to have at least one director who is ordinarily resident in Singapore. A European group establishing a regional subsidiary, a fund sponsor incorporating a holding vehicle, or a family office relocating assets to Singapore will frequently satisfy that requirement by appointing a locally resident individual who is understood, on all sides, to defer to the group.

Nominee directorships are also a long-standing and entirely legitimate feature of corporate governance more generally. They are used by venture capital and private equity investors, family offices, trustees, lenders and joint venture partners seeking board representation within layered ownership structures. Whatever the expectations of the party that procured the appointment, the nominee remains subject to the same fiduciary and statutory duties as any other director.

What has changed is the disclosure architecture built around the arrangement. Between 2017 and 2026 Singapore moved from a private register kept at the company’s registered office to a centralised filing with the national registrar, coupled with the licensing of intermediaries who arrange nominee appointments and materially higher personal exposure for the directors themselves.

The direction of travel will be familiar to readers in the European Union. Article 66 of the Anti-Money Laundering Regulation (Regulation (EU) 2024/1624) requires nominee shareholders and nominee directors to maintain adequate, accurate and up-to-date information on the identity of their nominator and of the nominator’s beneficial owners, and to disclose that information, together with their own nominee status, to the legal entity. Article 10 of Directive (EU) 2024/1640 requires that information on nominee arrangements be held in a central register in the Member State in which the entity is created. Both apply from 10 July 2027.

Singapore’s regime has therefore been operating, in substantially the same shape, during precisely the period in which European practitioners will be preparing for theirs. It is worth attention less as a piece of foreign law than as a working preview of the questions Article 66 will raise. Who counts as a nominee? Who counts as the nominator? And what happens when the formal answer and the factual answer diverge?

2. The Singapore framework in outline

Part 11A of the Companies Act 1967 now carries three related registers:
●    the register of registrable controllers (RORC), which is Singapore’s beneficial ownership register (section 386AF);
●    the register of nominee directors (ROND) (sections 386AKA and 386AL); and
●    the register of nominee shareholders (RONS) (sections 386ALA and 386ALB).

The ROND was introduced in 2017 as a private register maintained at the registered office. The Companies and Limited Liability Partnerships (Miscellaneous Amendments) Act 2024, in force from 16 June 2025, required its contents to be filed centrally with the Accounting and Corporate Regulatory Authority (ACRA). Existing companies had until 31 December 2025 to make the initial filing. Companies incorporated on or after 16 June 2025 file on incorporation. Subsequent changes must be filed within two business days, which is a demanding cadence by international standards and one that sits uneasily with how quickly board changes are actually communicated to corporate secretarial providers. Foreign companies registered in Singapore are subject to the same obligations.

Access is deliberately calibrated. The fact that a director holds office as a nominee is shown on the company’s publicly available business profile. The particulars of the nominator are not. Those are available to public agencies for the administration or enforcement of written law. The maximum fine for failure to maintain or to file the register was raised from S$5,000 to S$25,000.

Two further layers complete the picture. The Corporate Service Providers Act 2024, in force from 9 June 2025, prohibits a person from acting as a nominee director by way of business unless the appointment is arranged by an ACRA-registered corporate service provider which has assessed the individual as fit and proper. And the Corporate and Accounting Laws (Amendment) Act 2025, with selected provisions commencing on 6 May 2026, raised the maximum fine for breach of the core directors’ duties in section 157 from S$5,000 to S$20,000, with imprisonment of up to 12 months for serious offences, and introduced disqualification on conviction for money laundering offences under the Corruption, Drug Trafficking and Other Serious Crimes (Confiscation of Benefits) Act 1992.

Read together, the three instruments do three different things: they compel disclosure of the relationship, they regulate the gatekeeper who arranges it, and they raise the personal cost of treating the office as a formality. The last of these is the one most often missed by foreign clients, who tend to think of the nominee directorship as a filing requirement rather than as an appointment carrying unlimited fiduciary exposure.

3. The statutory test

Section 386AL(8) of the Companies Act 1967 adopts a deliberately broad and substance-driven definition. A director is a nominee if he or she is accustomed or under an obligation, whether formal or informal, to act in accordance with the directions, instructions or wishes of any other person.

Three features of that formulation deserve emphasis for a reader coming to it from a European register regime.

First, the test is functional rather than formal. It asks what the director in fact does, not how the appointment was papered. A director appointed under an express contractual nomination right may fall outside it. A director appointed by ordinary resolution, with no documentation at all, may fall within it.

Second, the identity of the "other person" is unconstrained. It is not confined to shareholders or to constitutional appointors. It extends to founders, sponsors, lenders, parent companies, trustees, protectors and beneficial owners, and to persons who hold no interest in the company whatsoever.

Third, the words "whether formal or informal" defeat structuring. Section 386AL collapses the distinctions that careful corporate architecture or contractual drafting might otherwise create. It operates alongside, and in places overlaps with, the doctrines of shadow directorship and de facto directorship, reinforcing a broader principle familiar in most common law systems: liability and disclosure follow conduct, not labels.
The significance of the provision lies in its downstream effects. Those are the obligation to record and file the nominee relationship, and the undiminished primacy of the fiduciary duties owed to the company. The scenarios below illustrate how the test is likely to operate across arrangements that international practitioners encounter routinely.

4. Identifying the nominator: four recurring scenarios

4.1 Founder-appointed and investor-appointed directors

The statutory definition applies identically regardless of who procures the appointment, but the commercial context differs. Founder-appointed directors are typically trusted associates, family members or senior executives expected to carry the founder’s vision for the business. Investor-appointed directors are nominated under contractual rights in shareholders’ agreements or subscription documents and are expected to protect the investor’s financial and governance interests.

Those differing objectives do not alter the analysis. In each case the question under section 386AL(8) is whether the director is accustomed, or under an obligation, to act in accordance with the directions of the founder, the investor or another person. The identity of the appointing party matters far less than the actual working relationship between that party and the director.

4.2 Private equity and venture capital board rights

In the private equity and venture capital context, board appointment rights, vetoes and reserved matters provide a structural platform for influence. They do not by themselves determine nominee status, because the statutory test remains conduct-based.

Whether an investor-appointed director is a nominee director is a question of fact. A director who exercises independent judgment consistently with his or her fiduciary duties may fall outside the definition notwithstanding the existence of an express appointment right. Conversely, where the evidence shows that the director habitually acts in accordance with an investor’s directions or wishes, nominee status may arise irrespective of what the documentation says. Appointment rights create the opportunity for influence. It is the practical exercise of that influence that satisfies the test.

This has a practical consequence for the transactional lawyer. The same shareholders’ agreement may produce different filing outcomes in respect of two directors appointed under the same clause, and the outcome may change over the life of the investment without any amendment to the document. Nominee status is not a term of the deal. It is an ongoing factual characterisation which has to be monitored.

4.3 Trust structures

Trust structures involve multiple layers of legal and beneficial ownership, with trustees, protectors, investment committees and beneficiaries exercising varying degrees of influence over companies held within the structure. The breadth of section 386AL ensures that a nominee arrangement cannot escape disclosure merely because the source of influence arises through a trust relationship rather than through direct share ownership. A director who consistently follows the directions of a trustee, a beneficiary or another person connected with the trust is a nominee director. Because the "other person" need not be a shareholder or a constitutional appointor, the trust cannot be used to obscure effective control.

In practice this is among the harder cases. A director may be formally appointed by a corporate trustee, while the trustee acts on the recommendations of a protector or an investment committee, which in turn responds to the settlor or a family principal. Identifying the relevant nominator requires an examination of how the arrangement actually operates in order to locate the person whose directions, instructions or wishes the director is in fact accustomed or obliged to follow, rather than tracing the formal chain of legal ownership. Where the chain is genuinely layered, the analysis should be documented at the time it is performed, because it will be revisited years later by a regulator, a liquidator or an opposing party who has the benefit of hindsight.

4.4 Corporate groups

In corporate groups it is ordinary for subsidiary directors to receive strategic guidance from the parent or from group management. This is an unremarkable feature of group governance and does not, without more, give rise to nominee status.

The enquiry remains whether the director is accustomed, or under an obligation, to act in accordance with the directions, instructions or wishes of the parent or another group entity. Where that threshold is crossed the director may be a nominee director within section 386AL, with the result that group-level influence over the subsidiary board becomes a matter of record. For European groups this is the scenario most likely to be overlooked, because the relationship that triggers the analysis is the one that feels least like a nominee arrangement.

5. Shadow control and informal influence

The phrase "whether formal or informal" brings shadow control squarely within the provision. A person may simultaneously be a nominator for ROND purposes and a shadow director at common law. The Singapore test for the latter was set out in Raffles Town Club Pte Ltd v Lim Eng Hock Peter and others [2010] SGHC 163, where Chan Seng Onn J observed at [45]:

It can thus be safely said that a "shadow director" is one "in accordance with whose instructions and directions the directors are accustomed to act". By "accustomed", this means that there must be a "pattern of behaviour" (per Millett J in Re Hydrodam (Corby) Ltd [1994] BCC 161 at 163) on the part of the rest of the directors in complying with the shadow director’s directions or instructions.

The two concepts are related but not identical, and the distinction repays attention. Shadow directorship asks whether the board, as a body, is accustomed to act on the instructions of an outsider. Section 386AL asks whether an individual director is accustomed or obliged to act on the directions of another person. The unit of analysis differs, but the evidence is the same: board minutes, correspondence, the sequence in which decisions are communicated, and the pattern of who is consulted before a matter reaches the board.

The same reasoning captures informal influence more generally. A director who consistently acts on another’s wishes is a nominee director even in the absence of any appointment right or contractual obligation. This dovetails with the concept of the de facto director, where liability attaches on the basis of conduct rather than title. The practical point is that a single body of evidence can support three separate characterisations at once, with consequences for disclosure, for duty and for personal liability.

6. The comparative picture

Singapore’s approach reflects the revised Financial Action Task Force Recommendation 24, which requires countries to have mechanisms ensuring that nominee arrangements are not misused, either by requiring nominees to disclose their status and their nominator to the registry, or by licensing nominees and requiring them to keep records. Singapore has done both, through the central ROND and through the Corporate Service Providers Act 2024 respectively.

Two comparative observations may be useful to a European readership.

The first concerns access. Following the judgment of the Court of Justice in Joined Cases C-37/20 and C-601/20, WM and Sovim SA v Luxembourg Business Registers, general public access to beneficial ownership registers could not be sustained, and Directive (EU) 2024/1640 has rebuilt access around competent authorities, obliged entities and persons demonstrating a legitimate interest. Singapore, which never adopted a public beneficial ownership register, has arrived at a comparable equilibrium by a different route: the existence of a nominee relationship is public, the identity of the nominator is not. For clients accustomed to weighing transparency obligations against privacy exposure, that split is worth understanding precisely, because the two limbs are frequently conflated in cross-border due diligence.

The second concerns where the obligation sits. Article 66 of the AMLR places the duty on the nominee, and requires the nominee to identify not only the nominator but the nominator’s beneficial owners. Singapore distributes the obligation differently. The director must notify the company of the nominee relationship and the nominator’s particulars; the company must maintain the register and file it; and the look-through to ultimate beneficial ownership is handled through the separate controllers register rather than through the ROND. The end state is similar. The compliance workflow, and the person who bears the criminal exposure if it fails, is not.

The United Kingdom offers a third model again, with a persons-with-significant-control regime that captures control without a dedicated nominee director register, supplemented by identity verification for directors under the Economic Crime and Corporate Transparency Act 2023. A group operating across Singapore, the European Union and the United Kingdom will therefore be reporting overlapping but non-identical facts to three registries on three different bases and three different timetables. That is a coordination problem, not merely a filing one.

7. Practical guidance

7.1 Treat nominee status as a conduct-based inquiry

The section 386AL test is inherently factual. It turns on whether there is a pattern of habitual compliance or an expectation of adherence to another’s directions. Formal labels, whether "investor-appointed" or "independent", are not determinative. A court or regulator will look to board minutes, correspondence and decision-making patterns to assess whether influence rises to the level captured by the section. Advise clients accordingly at the point of appointment, not at the point of filing.

7.2 Anticipate the overlap with shadow control

Nominee status will frequently coincide with shadow directorship, particularly in three settings: private equity, venture capital and financing structures with strong control rights; intra-group governance with parent-driven decision-making; and trust and beneficial ownership arrangements. The overlap increases exposure to fiduciary and statutory liability and reinforces that the duties are owed to the company. Since 6 May 2026 the consequences of getting this wrong include fines of up to S$20,000 and, for serious breaches, imprisonment.

7.3 Align disclosure, documentation and practice

Filing must reflect actual influence rather than formal arrangements. Disclosure is mandatory once the test is met, whether the nominator is a founder, an investor, a trustee or a parent. In practice this requires accurate identification of the nominator, governance processes which evidence independent judgment, and documentation consistent with how decisions are in fact taken. Any divergence between form and practice will attract scrutiny in disputes, in insolvency and on regulatory review, and contemporaneous records of instructions and decision-making are what will meet the evidential threshold when that day comes.

7.4 Build the two business day cycle into the calendar

The filing deadline for changes is short and the penalty is not trivial. Board changes in a group with multiple Singapore entities should be routed through a single process which captures the nominee question at the same moment as the appointment itself, rather than at the next periodic compliance review.

7.5 Check the intermediary

Where a nominee directorship is arranged commercially, it must now be arranged through an ACRA-registered corporate service provider. Legacy arrangements entered into before June 2025 with unregistered individuals should be reviewed and, where necessary, restructured.

8. Conclusion

Singapore’s Register of Nominee Directors does not prohibit anything. It records a relationship which has always been lawful and remains commercially useful, and it does so on a test which looks past the documents to the conduct. That is its most instructive feature for practitioners elsewhere. As Article 66 of the AMLR comes into application in July 2027, the central question for European counsel will be the same one Singapore counsel have been answering since 2017: not whether a nominee arrangement exists on paper, but whose wishes the director is in fact accustomed to follow, and whether the client can demonstrate the answer.

Azmul HAQUE & Natalia MOMOT
Collyer Law LLC, Singapore